Clinical Trial Update: Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy and bevacizumab before surgery, followed by radiolabeled monoclonal antibody therapy, for metastatic colorecta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Chemotherapy (unspecified)
• Radiolabeled Monoclonal Antibody Therapy

Snippet

Sponsor: City of Hope Medical Center | Conditions: Liver Metastases, Recurrent Colon Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-06-20